A M I No. 16.03 / 2025 26 Bevacizumab Inj. 100 Mg
Tender Title | A M I No. 16.03 / 2025 26 Bevacizumab Inj. 100 Mg | ||
Tender ID | NA | Tender Reference Number | 82251859 |
Tender Type | Limited | ||
Tender Opening Date | 2025-01-03 10:47 AM | Tender Closing Date | 2025-01-20 05:30 AM |
Tender Value | Refer Document | Tender Location | New Delhi , Central Delhi , Delhi |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2025-01-03 10:47 AM | Bid Opening Date | 2025-01-20 05:30 AM |
Document Download Start Date | 2025-01-03 10:47 AM | Document Download End Date | 2025-01-20 05:30 AM |
Bid Submission Start Date | 2025-01-03 10:47 AM | Bid Submission End Date | 2025-01-20 05:30 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | ₹ 53,520 |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, Stores/Northern Railway, invites tenders for the supply of BEVACIZUMAB INJ. 100 MG (Tender Reference Number: 82251859). This limited tender, categorized under Goods and specifically Railway related Products, requires interested parties to submit bids for A.M.I. No. 16.03/2025-26. The tender document is available for download from 03-Jan-2025, 04:17 PM to 20-Jan-2025, 11:00 AM. Bids must be submitted electronically between 03-Jan-2025, 04:17 PM and 20-Jan-2025, 11:00 AM; the bid opening will be held on 20-Jan-2025, 11:00 AM. A tender fee is not applicable, however, an Earnest Money Deposit (EMD) of ₹53,520 is required. For complete details, refer to the tender document. Contact information for the tendering authority is: STORES/NORTHERN RLY, 2nd Floor, Annexe- I Baroda House, K G marg New Delhi.
Get Hassle free financing for your business
Office Inviting Bids | Stores/northern Rly |
Address | 2nd Floor, Annexe- I Baroda House, K G Marg New Delhi |
Contact Details | NA |
NA | |
Website | NA |
A M I No- 16.05/2025-26 Bevacizumab Inj 400mg..read more
A M I No. 16.76 / 2025-26 Trastuzumab Inj. 440 Mg..read more
A M I No - 16.51/2025-26 Nimotuzumab Inj 200mg..read more
A M I No - 16.23/2025-26 Denosumab Inj 120mg..read more
A M I No - 16.67 / 2025-26 Ramucirumab Inj 500mg..read more
All the major brands in each raw material category